Vaxart
VXRT
#9581
Rank
โ‚น10.43 B
Marketcap
โ‚น43.12
Share price
-10.00%
Change (1 day)
21.19%
Change (1 year)

Revenue for Vaxart (VXRT)

Revenue in 2026 (TTM): โ‚น22.86 Billion

According to Vaxart's latest financial reports the company's current revenue (TTM ) is โ‚น24.49 Billion. In 2025 the company made a revenue of โ‚น21.29 Billion an increase over the revenue in the year 2024 that were of โ‚น2.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vaxart from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น22.86 B7.35%
2025 โ‚น21.29 B765.06%
2024 โ‚น2.46 B300.8%
2023 โ‚น0.61 B6837.83%
2022 โ‚น8.85 M-86.66%
2021 โ‚น66.39 M-77.56%
2020 โ‚น0.29 B-57.93%
2019 โ‚น0.70 B141.83%
2018 โ‚น0.29 B-41.61%
2017 โ‚น0.49 B-24.44%
2016 โ‚น0.65 B-25.98%
2015 โ‚น0.89 B-73.24%
2014 โ‚น3.32 B2.49%
2013 โ‚น3.24 B382.81%
2012 โ‚น0.67 B-14.33%
2011 โ‚น0.78 B-49.96%
2010 โ‚น1.56 B222.29%
2009 โ‚น0.48 B
2006 โ‚น3.98 B-11.25%
2005 โ‚น4.48 B-42.39%
2004 โ‚น7.78 B-3.16%
2003 โ‚น8.03 B-14.45%
2002 โ‚น9.39 B-17.06%
2001 โ‚น11.33 B6.12%
2000 โ‚น10.67 B5.14%
1999 โ‚น10.15 B-1.75%
1998 โ‚น10.33 B15.01%
1997 โ‚น8.98 B4.26%
1996 โ‚น8.62 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚น13.28 B-45.76%๐Ÿ‡บ๐Ÿ‡ธ USA